ABSTRACT
Podosomes are protrusive structures implicated in macrophage extracellular matrix degradation and three-dimensional migration through cell barriers and the interstitium. Podosome formation and assembly are regulated by cytoskeleton remodeling requiring cytoplasmic tyrosine kinases of the Src and the Abl families. Considering that Abl has been reported to phosphorylate the guanine nucleotide exchange factor Sos1, eliciting its Rac-guanine nucleotide exchange factor activity, and Rac regulates podosome formation in myeloid cells and invadopodia formation in cancer cells, we addressed whether Sos1 is implicated in podosome formation and function in macrophages. We found that ectopically expressed Abl or the Src kinase Fgr phosphorylate Sos1, and the Src kinases Hck and Fgr are required for Abl and Sos1 phosphorylation and Abl/Sos1 interaction in macrophages. Sos1 localizes to podosomes in both murine and human macrophages, and its silencing by small interfering RNA results in disassembly of murine macrophage podosomes and a marked reduction of GTP loading on Rac. Matrix degradative capacity, three-dimensional migration through Matrigel, and transmigration through an endothelial cell monolayer of Sos1-silenced macrophages were inhibited. In addition, Sos1- or Abl-silenced macrophages, or macrophages treated with the selective Abl inhibitor imatinib mesylate had a reduced capability to migrate into breast tumor spheroids, the majority of cells remaining at the margin and the outer layers of the spheroid itself. Because of the established role of Src and Abl kinases to regulate also invadopodia formation in cancer cells, our findings suggest that targeting the Src/Abl/Sos1/Rac pathway may represent a double-edged sword to control both cancer-invasive capacities and cancer-related inflammation.
Subject(s)
Cell Movement/immunology , Macrophages/immunology , Neoplasms/immunology , Proto-Oncogene Proteins/immunology , SOS1 Protein/immunology , src-Family Kinases/immunology , Animals , COS Cells , Cell Movement/drug effects , Cell Movement/genetics , Chlorocebus aethiops , Humans , Imatinib Mesylate/pharmacology , Macrophages/pathology , Mice , Neoplasm Invasiveness/genetics , Neoplasm Invasiveness/immunology , Neoplasms/genetics , Neoplasms/pathology , Phosphorylation/drug effects , Phosphorylation/genetics , Phosphorylation/immunology , Podosomes , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-abl/antagonists & inhibitors , Proto-Oncogene Proteins c-abl/genetics , Proto-Oncogene Proteins c-abl/immunology , SOS1 Protein/genetics , rac GTP-Binding Proteins/genetics , rac GTP-Binding Proteins/immunology , src-Family Kinases/geneticsABSTRACT
MOTIVATION: Comparative studies are encouraged by the fast increase of data availability from the latest high-throughput techniques, in particular from functional genomic studies. Yet, the size of datasets, the challenge of complete orthologs findings and not last, the variety of identification formats, make information integration challenging. With HOMECAT, we aim to facilitate cross-species relationship identification and data mapping, by combining orthology predictions from several publicly available sources, a convenient interface for high-throughput data download and automatic identifier conversion into a Cytoscape plug-in, that provides both an integration with a large set of bioinformatics tools, as well as a user-friendly interface. AVAILABILITY: HOMECAT and the Supplementary Materials are freely available at http://www.cbmc.it/homecat/.
Subject(s)
Genomics/methods , Software , Animals , Mice , Oligonucleotide Array Sequence Analysis , Rats , Systems IntegrationABSTRACT
In many parts of the vertebrate nervous system, synaptic connections are remodeled during early postnatal life. Neural activity plays an important role in regulating one such rearrangement, synapse elimination, in the developing neuromuscular system, but there is little direct evidence on roles of pre- or postsynaptic activity in regulating synapse elimination in the developing brain. To address this issue, we expressed a chloride channel-yellow fluorescent protein fusion in cerebellar Purkinje cells (PCs) of transgenic mice to decrease their excitability. We then assessed elimination of supernumerary climbing fiber inputs to PCs. Individual PCs are innervated by multiple climbing fibers at birth; all but one are eliminated during the first three postnatal weeks in wild-type mice, but multiple innervation persists for at least three months in the transgenic mice. The normal redistribution of climbing fiber synapses from PC somata to proximal dendrites was also blunted in transgenics. These results show that normal electrical activity of the postsynaptic cell is required for it to attain a mature innervation pattern.
Subject(s)
Cerebellum/physiology , Excitatory Postsynaptic Potentials/physiology , Neurons/physiology , Synapses/physiology , Animals , Cell Line , Cerebellum/cytology , Cerebellum/growth & development , Chloride Channels/genetics , Chloride Channels/metabolism , Electrophysiology , Excitatory Postsynaptic Potentials/genetics , Fluorescent Antibody Technique , Humans , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Mice , Mice, Transgenic , Microscopy, Confocal , Motor Activity/physiology , Neurons/cytology , Neurons/metabolism , Purkinje Cells/cytology , Purkinje Cells/metabolism , Purkinje Cells/physiology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Superior Cervical Ganglion/cytology , TransfectionABSTRACT
Chorea-Acanthocytosis (ChAc) is a devastating, little understood, and currently untreatable neurodegenerative disease caused by VPS13A mutations. Based on our recent demonstration that accumulation of activated Lyn tyrosine kinase is a key pathophysiological event in human ChAc cells, we took advantage of Vps13a-/- mice, which phenocopied human ChAc. Using proteomic approach, we found accumulation of active Lyn, γ-synuclein and phospho-tau proteins in Vps13a-/- basal ganglia secondary to impaired autophagy leading to neuroinflammation. Mice double knockout Vps13a-/- Lyn-/- showed normalization of red cell morphology and improvement of autophagy in basal ganglia. We then in vivo tested pharmacologic inhibitors of Lyn: dasatinib and nilotinib. Dasatinib failed to cross the mouse brain blood barrier (BBB), but the more specific Lyn kinase inhibitor nilotinib, crosses the BBB. Nilotinib ameliorates both Vps13a-/- hematological and neurological phenotypes, improving autophagy and preventing neuroinflammation. Our data support the proposal to repurpose nilotinib as new therapeutic option for ChAc patients.
Subject(s)
Drug Delivery Systems/methods , Neuroacanthocytosis/drug therapy , Neuroacanthocytosis/enzymology , Protein Kinase Inhibitors/administration & dosage , src-Family Kinases/antagonists & inhibitors , Animals , Dasatinib/administration & dosage , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neuroacanthocytosis/genetics , Pyrimidines/administration & dosage , Vesicular Transport Proteins/genetics , Vesicular Transport Proteins/metabolism , src-Family Kinases/genetics , src-Family Kinases/metabolismABSTRACT
α-Bisabolol (BSB) is a plant-derived sesquiterpene alcohol able to trigger regulated cell death in transformed cells, while deprived of the general toxicity in several mouse models. Here, we investigated the involvement of lysosomal and mitochondrial compartments in the cytotoxic effects of BSB, with a specific focus on the BH3-only activator protein BID. We found that BSB particularly accumulated in cancer cell lines, displaying a higher amount of lipid rafts as compared to normal blood cells. By means of western blotting and microscopy techniques, we documented rapid BSB-induced BID translocation to lysosomes and mitochondria, both of them becoming dysfunctional. Lysosomal membranes were permeabilized, thus blocking the cytoprotective autophagic flux and provoking cathepsin B leakage into the cytosol. Multiple flow cytometry-based experiments demonstrated the loss of mitochondrial membrane potential due to pore formation across the lipid bilayer. These parallel events converged on neoplastic cell death, an outcome significantly prevented by BID knockdown. Therefore, BSB promoted BID redistribution to the cell death executioner organelles, which in turn activated anti-autophagic and proapoptotic mechanisms. This is an example of how xenohormesis can be exploited to modulate basic cellular programs in cancer.
Subject(s)
Apoptosis/drug effects , BH3 Interacting Domain Death Agonist Protein/metabolism , Lysosomes/metabolism , Mitochondria/metabolism , Monocyclic Sesquiterpenes/pharmacology , Autophagy/drug effects , Benzimidazoles/pharmacology , Carbocyanines/pharmacology , Cell Cycle/drug effects , Cell Line , G(M1) Ganglioside/metabolism , Gene Knockdown Techniques , Humans , Lysosomes/drug effects , Membrane Microdomains/metabolism , Membrane Potential, Mitochondrial/drug effects , Membrane Proteins/metabolism , Mitochondria/drug effects , Protein Transport/drug effectsABSTRACT
Reelin, an extracellular matrix protein, plays an important role in the regulation of neuronal migration and cortical lamination in the developing brain. Little is known, however, about the role of this protein in axonal regeneration. We have previously shown that Reelin is secreted by Schwann cells in the peripheral nerve compartment during postnatal development and that it is up-regulated following nerve injury in adult mice. In this work, we generated mice deficient in Reelin (reeler) that express yellow fluorescent protein (YFP) in a subset of neurons and examined the axonal regeneration following nerve crush. We found that axonal regeneration was significantly altered compared with wild-type mice. By contrast, retrograde tracing with Fluorogold dye after sciatic nerve crush was unaffected in these mutants, being comparable with normal axonal transport observed in wild-type. These results indicate that the absence of Reelin impairs axonal regeneration following injury and support a role for this protein in the process of peripheral nerve regeneration.
Subject(s)
Cell Adhesion Molecules, Neuronal/metabolism , Extracellular Matrix Proteins/metabolism , Gene Expression Regulation/physiology , Nerve Regeneration/physiology , Nerve Tissue Proteins/metabolism , Peripheral Nervous System Diseases/genetics , Peripheral Nervous System Diseases/physiopathology , Serine Endopeptidases/metabolism , Animals , Cell Adhesion Molecules, Neuronal/deficiency , Extracellular Matrix Proteins/deficiency , Gene Expression Regulation/genetics , Luminescent Proteins/biosynthesis , Luminescent Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Tissue Proteins/deficiency , Reelin Protein , Serine Endopeptidases/deficiency , Stilbamidines/metabolismABSTRACT
One of the earliest pathological features characterizing Alzheimer's disease (AD) is the loss of dendritic spines. Among the many factors potentially mediating this loss of neuronal connectivity, the contribution of Rho-GTPases is of particular interest. This family of proteins has been known for years as a key regulator of actin cytoskeleton remodeling. More recent insights have indicated how its complex signaling might be triggered also in pathological conditions. Here, we showed that the Rho-GTPase family member Rac1 levels decreased in the frontal cortex of AD patients compared to non-demented controls. Also, Rac1 increased in plasma samples of AD patients with Mini-Mental State Examination < 18 compared to age-matched non demented controls. The use of different constitutively active peptides allowed us to investigate in vitro Rac1 specific signaling. Its activation increased the processing of amyloid precursor protein and induced the translocation of SET from the nucleus to the cytoplasm, resulting in tau hyperphosphorylation at residue pT181. Notably, Rac1 was abnormally activated in the hippocampus of 6-week-old 3xTg-AD mice. However, the total protein levels decreased at 7-months. A rescue strategy based on the intranasal administration of Rac1 active peptide at 6.5 months prevented dendritic spine loss. This data suggests the intriguing possibility of a dual role of Rac1 according to the different stages of the pathology. In an initial stage, Rac1 deregulation might represent a triggering co-factor due to the direct effect on Aß and tau. However, at a later stage of the pathology, it might represent a potential therapeutic target due to the beneficial effect on spine dynamics.
Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , rac1 GTP-Binding Protein/metabolism , tau Proteins/metabolism , Aged , Aged, 80 and over , Animals , Cells, Cultured , Cognition Disorders/metabolism , Cognition Disorders/physiopathology , Dendritic Spines/metabolism , Dendritic Spines/pathology , Dendritic Spines/ultrastructure , Disease Models, Animal , Embryo, Mammalian , Fatty Acids, Unsaturated/pharmacology , Gene Expression Regulation/genetics , Humans , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neuroblastoma/pathology , Neurons/drug effects , Neurons/metabolism , Neurons/ultrastructure , Phosphorylation/physiology , Presenilin-1/genetics , Presenilin-1/metabolism , tau Proteins/geneticsABSTRACT
BACKGROUND: Protein tyrosine phosphatase receptor gamma (PTPRG) is a ubiquitously expressed member of the protein tyrosine phosphatase family known to act as a tumor suppressor gene in many different neoplasms with mechanisms of inactivation including mutations and methylation of CpG islands in the promoter region. Although a critical role in human hematopoiesis and an oncosuppressor role in chronic myeloid leukemia (CML) have been reported, only one polyclonal antibody (named chPTPRG) has been described as capable of recognizing the native antigen of this phosphatase by flow cytometry. Protein biomarkers of CML have not yet found applications in the clinic, and in this study, we have analyzed a group of newly diagnosed CML patients before and after treatment. The aim of this work was to characterize and exploit a newly developed murine monoclonal antibody specific for the PTPRG extracellular domain (named TPγ B9-2) to better define PTPRG protein downregulation in CML patients. METHODS: TPγ B9-2 specifically recognizes PTPRG (both human and murine) by flow cytometry, western blotting, immunoprecipitation, and immunohistochemistry. RESULTS: Co-localization experiments performed with both anti-PTPRG antibodies identified the presence of isoforms and confirmed protein downregulation at diagnosis in the Philadelphia-positive myeloid lineage (including CD34+/CD38bright/dim cells). After effective tyrosine kinase inhibitor (TKI) treatment, its expression recovered in tandem with the return of Philadelphia-negative hematopoiesis. Of note, PTPRG mRNA levels remain unchanged in tyrosine kinase inhibitors (TKI) non-responder patients, confirming that downregulation selectively occurs in primary CML cells. CONCLUSIONS: The availability of this unique antibody permits its evaluation for clinical application including the support for diagnosis and follow-up of these disorders. Evaluation of PTPRG as a potential therapeutic target is also facilitated by the availability of a specific reagent capable to specifically detect its target in various experimental conditions.
Subject(s)
Antibodies, Monoclonal/analysis , Immunohistochemistry/methods , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Receptor-Like Protein Tyrosine Phosphatases, Class 5/analysis , Animals , Antibodies, Monoclonal/immunology , Blotting, Western , Down-Regulation , Gene Expression Regulation, Leukemic , Humans , Immunoprecipitation , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Mice , Mice, Inbred BALB C , Receptor-Like Protein Tyrosine Phosphatases, Class 5/genetics , Receptor-Like Protein Tyrosine Phosphatases, Class 5/immunology , Tumor Cells, CulturedABSTRACT
Alzheimer's disease (AD) is characterized by a wide loss of synapses and dendritic spines. Despite extensive efforts, the molecular mechanisms driving this detrimental alteration have not yet been determined. Among the factors potentially mediating this loss of neuronal connectivity, the contribution of Rho GTPases is of particular interest. This family of proteins is classically considered a key regulator of actin cytoskeleton remodeling and dendritic spine maintenance, but new insights into the complex dynamics of its regulation have recently determined how its signaling cascade is still largely unknown, both in physiological and pathological conditions. Here, we review the growing evidence supporting the potential involvement of Rho GTPases in spine loss, which is a unanimously recognized hallmark of early AD pathogenesis. We also discuss some new insights into Rho GTPase signaling framework that might explain several controversial results that have been published. The study of the connection between AD and Rho GTPases represents a quite unchartered avenue that holds therapeutic potential.
Subject(s)
Alzheimer Disease/pathology , Dendritic Spines/metabolism , Signal Transduction/physiology , Synapses/pathology , rho GTP-Binding Proteins/metabolism , Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Animals , Dendritic Spines/pathology , Humans , Synapses/metabolismABSTRACT
The receptor protein tyrosine phosphatase γ (Ptprg-RPTPγ) is a receptor protein widely expressed in many tissues, including the central nervous system (CNS). Several RPTPγ isoforms are expressed in the brain during development and in adulthood, but their distribution and role are unknown. In this study, we investigated the distribution of some RPTPγ isoforms in the adult brain using antibodies against the epitopes localized in the C- and in the N-terminal domains of the full length isoform of RPTPγ. We found a predominant and widespread neuronal positivity throughout the neocortex, hippocampus, striatum and in many nuclei of the brainstem and cerebellum. At least 2 distinct isoforms that can co-exist in various compartments in the same cell are detectable in different neuron types. Immunopositivity for epitopes located in both the N- and C-terminus domains were found in the neuropil of cortical and hippocampal neurons, whereas the N-terminal domain positivity was found in the soma, often without colocalization with its C-terminal counterpart. Among glial cells, some protoplasmic and perivascular astrocytes and the cerebellar Bergmann glia, express RPTPγ. The astrocytic expression of RPTPγ and putative processing isoforms of 120 and 80 kDa increases during neuroinflammation, in particular 24 h after LPS treatment. Activated astrocytes were found to be strongly positive for RPTPγ also in a mice model of Alzheimer's disease. Our results confirm previous findings and enrich the current knowledge of RPTPγ distribution in the CNS, highlighting a role of RPTPγ during neuroinflammation processes.
Subject(s)
Brain/enzymology , Receptor-Like Protein Tyrosine Phosphatases, Class 5/metabolism , Aging , Animals , Inflammation/enzymology , Mice, Inbred C57BL , Nerve Tissue Proteins/metabolism , Up-RegulationABSTRACT
Brain activity is associated with structural changes in the neural connections. However, in vivo imaging of the outer cortical layers has shown that dendritic spines, on which most excitatory synapses insist, are predominantly stable in adulthood. Changes in dendritic spines are governed by small GTPases of the Rho family through modulation of the actin cytoskeleton. Yet, while there are abundant data about this functional effect of Rho GTPases in vitro, there is limited evidence that Rho GTPase signaling in the brain is associated with changes in neuronal morphology. In the present work, both chronic in vivo two-photon imaging and Golgi staining reveal that the activation of Rho GTPases in the adult mouse brain is associated with little change of dendritic spines in the apical dendrites of primary visual cortex pyramidal neurons. On the contrary, considerable increase in spine density is observed (i) in the basal dendrites of the same neurons (ii) in both basal and apical dendrites of the hippocampal CA1 pyramidal cells. While confirming that Rho GTPase-dependent increase in spine density can be substantial, the study indicates region and dendrite selectivity with relative stability of superficial cortical circuits.
ABSTRACT
Several lines of evidence have supported the potential involvement of metal ions in the etiology of Alzheimer's Disease (AD). However, the molecular mechanisms underlying this interaction are still partially unknown. Previous work from our laboratory has shown that ß-amyloid peptide (Aß) aggregation was strongly influenced by the conjugation of the peptide with few metal ions (aluminum, copper, zinc, and iron) that are found in high concentrations in the senile plaque core. The binding of aluminum (Al) to Aß specifically stabilized the peptide in an oligomeric conformation. Here, we show that the aggregation of Aß-Al was boosted by sodium dodecyl sulfate, a detergent that mimics some characteristics of biological membrane, suggesting a potential role for membrane components in the Aß aggregation process. Notably, we also found that Aß-Al caused mitochondrial dysfunction and reactive oxygen species production in primary cortical neurons. Aß-Al strongly promoted also alterations in cytoskeleton network as shown by the increased F-actin expression and the occurrence of neuritic beading. Interestingly, the neurotoxic effect of this metal complex was associated with a decreased mRNA expression of ubiquitin thiolesterase, an ubiquitin-dependent protein involved in catabolic process, and by the increased expression of glutaminyl cyclase, responsible for pathological post-translational modification of Aß. These results suggest that, in neuronal cells, Aß-Al can induce relevant detrimental changes that resemble pathological hallmarks of AD.
Subject(s)
Aluminum/metabolism , Amyloid beta-Peptides/metabolism , Cerebral Cortex/metabolism , Cytoskeleton/metabolism , Neurons/metabolism , Reactive Oxygen Species/metabolism , Aluminum/chemistry , Amyloid beta-Peptides/chemistry , Animals , Cells, Cultured , Cerebral Cortex/cytology , Cerebral Cortex/enzymology , Electron Transport Complex I/metabolism , Mice , Neurons/enzymology , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Sodium Dodecyl Sulfate/chemistryABSTRACT
In adult mammals, after optic nerve injury, retinal ganglion cells (RGCs) do not regenerate their axons and most of them die by apoptosis within a few days. Recently, several strategies that activate neuronal intracellular pathways were proposed to prevent such degenerative processes. The rho-related small GTPase Rac1 is part of a complex, still not fully understood, intracellular signaling network, mediating in neurons many effects, including axon growth and cell survival. However, its role in neuronal survival and regeneration in vivo has not yet been properly investigated. To address this point we intravitreally injected selective cell-penetrating Rac1 mutants after optic nerve crush and studied the effect on RGC survival and axonal regeneration. We injected two well-characterized L61 constitutively active Tat-Rac1 fusion protein mutants, in which a second F37A or Y40C mutation confers selectivity in downstream signaling pathways. Results showed that, 15 days after crush, both mutants were able to improve survival and to prevent dendrite degeneration, while the one harboring the F37A mutation also improved axonal regeneration. The treatment with F37A mutant for one month did not improve the axonal elongation respect to 15 days. Furthermore, we found an increase of Pak1 T212 phosphorylation and ERK1/2 expression in RGCs after F37A treatment, whereas ERK1/2 was more activated in glial cells after Y40C administration. Our data suggest that the selective activation of distinct Rac1-dependent pathways could represent a therapeutic strategy to counteract neuronal degenerative processes in the retina.
Subject(s)
Nerve Regeneration/physiology , Neuropeptides/physiology , Optic Nerve/physiopathology , Retinal Ganglion Cells/physiology , rac1 GTP-Binding Protein/physiology , Animals , Axons/metabolism , Axons/physiology , Cell Survival/genetics , Cell Survival/physiology , Fluorescent Antibody Technique , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Mice , Mice, Inbred CBA , Mice, Transgenic , Microscopy, Confocal , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Mutation , Nerve Crush/adverse effects , Nerve Regeneration/genetics , Neuropeptides/genetics , Neuropeptides/metabolism , Optic Nerve/metabolism , Optic Nerve/surgery , Optic Nerve Injuries/etiology , Optic Nerve Injuries/genetics , Optic Nerve Injuries/physiopathology , Phosphorylation , Retinal Ganglion Cells/metabolism , Signal Transduction/genetics , Signal Transduction/physiology , Time Factors , p21-Activated Kinases/metabolism , rac1 GTP-Binding Protein/genetics , rac1 GTP-Binding Protein/metabolismABSTRACT
BACKGROUND: The functioning of the nervous system depends upon the specificity of its synaptic contacts. The mechanisms triggering the expression of the appropriate receptors on postsynaptic membrane and the role of the presynaptic partner in the differentiation of postsynaptic structures are little known. METHODS AND FINDINGS: To address these questions we cocultured murine primary muscle cells with several glutamatergic neurons, either cortical, cerebellar or hippocampal. Immunofluorescence and electrophysiology analyses revealed that functional excitatory synaptic contacts were formed between glutamatergic neurons and muscle cells. Moreover, immunoprecipitation and immunofluorescence experiments showed that typical anchoring proteins of central excitatory synapses coimmunoprecipitate and colocalize with rapsyn, the acetylcholine receptor anchoring protein at the neuromuscular junction. CONCLUSIONS: These results support an important role of the presynaptic partner in the induction and differentiation of the postsynaptic structures.
Subject(s)
Cell Differentiation , Muscle Fibers, Skeletal/cytology , Muscle Proteins/physiology , Neurons/cytology , Synapses/physiology , Animals , Coculture Techniques , Glutamic Acid , Mice , Neuromuscular Junction , Neurons/ultrastructure , Post-Synaptic Density/chemistry , Post-Synaptic Density/ultrastructure , Presynaptic Terminals/ultrastructure , Receptors, Cholinergic , Receptors, Glutamate , Synapses/ultrastructureABSTRACT
The role of insulin-like growth factor 1 (IGF1) pathway as regulator of aging and age-related diseases is increasingly recognized. Recent evidence has been provided that neuronal IGF1-R increases during aging leading to activation of a signaling pathway that causes an increased production of amyloid beta-peptide, the principal event in the pathogenesis of Alzheimer's disease. Here, by using long-term neuronal cultures as a model of aging, we show that astroglial cells are required to upregulate the expression of IGF1-R in neurons during in vitro senescence. Moreover, evidence is provided that the cross-talk between astrocytes and neurons is independent of cell-to-cell contact, and it is mediated by low molecular weight soluble factor(s) released by astrocytes in culture medium. These results suggest that astrocytes could play an important role in aging and age-related pathological processes.
Subject(s)
Aging/physiology , Astrocytes/metabolism , Cerebral Cortex/cytology , Neurons/metabolism , Receptor, IGF Type 1/metabolism , Animals , Astrocytes/cytology , Cells, Cultured , Cerebral Cortex/physiology , Coculture Techniques , Culture Media, Conditioned/metabolism , Neurons/cytology , Rats , Rats, Sprague-Dawley , Signal Transduction/physiologyABSTRACT
Synapse competition and elimination are a general developmental process both in central and in peripheral nervous systems that is strongly activity dependent. Some common features regulate synapse competition, and one of these is an application to development of the Hebb's postulate of learning: repeated coincident spike activity in competing presynaptic inputs on the same target cell inhibits competition, whereas noncoincident activity promotes weakening of some of the inputs and ultimately their elimination. Here we report experiments that indicate that the development of muscle innervation (initial polyneuronal innervation and subsequent synapse elimination) follows the Hebb's paradigm. We utilized two different models of muscle reinnervation in the adult rat: 1) we crushed nerves going to soleus or extensor digitorum longus muscles, to activate regeneration of the presynaptic component of the neuromuscular junctions (NMJ), or 2) we injected the soleus muscle with Marcaine (a myotoxic agent) to activate regeneration of the postsynaptic component, the muscle fiber. A condition of transient polyneuronal innervation occurs during NMJ regeneration in both cases, although the two models differ insofar as the relative strength of the competing inputs is concerned. During the period of competition (a few days or weeks, in Marcaine or crush experiments, respectively), we imposed a synchronous firing pattern on the competing inputs by stimulating motor axons distal to a chronic conduction block and demonstrated that this procedure strongly inhibits synapse elimination, with respect to control muscles in which regeneration occurs under natural impulse activity of motoneurons.
Subject(s)
Models, Biological , Muscle, Skeletal/physiology , Neuromuscular Junction/physiology , Anesthetics, Local/pharmacology , Animals , Bupivacaine/pharmacology , Electric Stimulation/methods , Male , Muscle Denervation/methods , Muscle, Skeletal/drug effects , Muscle, Skeletal/radiation effects , Nerve Crush/methods , Nerve Regeneration/drug effects , Neuromuscular Junction/drug effects , Neuromuscular Junction/radiation effects , Rats , Rats, Wistar , Receptors, Nicotinic/metabolism , Tetrodotoxin/pharmacology , Time Factors , alpha7 Nicotinic Acetylcholine ReceptorABSTRACT
Reelin is an extracellular matrix protein which is critical for the positioning of migrating post-mitotic neurons and the laminar organization of several brain structures during development. We investigated the expression and localization of Reelin in the rodent peripheral nerve during postnatal development and following crush injury in the adult stage. As shown with Western blotting, immunocytochemistry and RT-PCR, Schwann cells in the developing peripheral nerve and in primary cultures from neonatal nerves produce and secrete Reelin. While Reelin levels are downregulated in adult stages, they are again induced following sciatic nerve injury. A morphometric analysis of sciatic nerve sections of reeler mice suggests that Reelin is not essential for axonal ensheathment by Schwann cells, however, it influences the caliber of myelinated axons and the absolute number of fibers per unit area. This indicates that Reelin may play a role in peripheral nervous system development and repair by regulating Schwann cell-axon interactions.